Jump to Navigation
Trends and Sentiments
Comments and Analysis
Nicole Kidman Shines At The 89th Academy Awards
'Et Tu?' The Only Question That Matters
Becton, Dickinson And Company: Non-Cyclical Revenues May...
The Fed Will Only Hike Twice This Year, Starting In June
Is There An Upside To The Sears Debacle?
11 of the weirdest and wackiest phone designs ever
Op-Ed: Smartphones as we know them will be dead in five...
Futures Movers: Oil prices rise modestly, overshadowed by...
Chinese New Year behind record New Zealand visitor...
Alibaba bets on global ambassadors for a cosmopolitan...
Emisphere: Crown Jewel In Oral B12
Analyzing Wednesday's Noteworthy Insider Buys And Sells
7 Healthcare Stocks With January Catalysts
Analyzing Friday's Noteworthy Insider Buys And Sells
Novel Cancer Treatment Gains Acceptance
Targeted Chemotherapy: The Perfect Balance Between Safety And Efficacy?
Hyper-Novel Investments For Targeting Cancer
Notable Micro Cap Insider Buys Last Week
Biotechnology And Drug Stocks Up For FDA Approval In August
Delcath Systems 's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Cancer Treatment Need Is The Mother Of Novel Solutions
Delcath Systems: An Exclusive Interview With ROTH Capital Senior Analyst
Interview: Delcath's CEO Provides Details About The Resubmission Of The FDA's New Drug Application For CHEMOSAT
Delcath Systems: A Frustrating Stock With Quite A Bit Of Value Potential
Biotech Weekend Recap: Bears, Bears Everywhere
Delcath Systems Management Discusses Q3 2012 Results - Earnings Call Transcript
Delcath Systems' CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)
Q3 2012 Pharma Company Updates Indicate Upcoming Catalysts
Three Reasons Delcath Systems Appears Undervalued
Is Delcath The Post-Celsion Play On Liver Cancer?
Cancer Radiation Stocks To Consider: Delcath, Spectrum And IsoRay
The Business Of Cancer
Delcath Systems: 'Improving The Bicycle' In Chemotherapy
Delcath Systems: Bullish On Melblez FDA Panel Vote And Subsequent Approval
Activity centre and law firms listed as Best...
Environmental Degradation Goes Global
EUR/GBP: 1.1753 USD/EUR: 1.0566 JPY/USD: 112.1010
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions